Literature DB >> 7539637

Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea.

G D Phillips1, A M Stone, B D Jones, J C Schultz, R A Whitehead, D R Knighton.   

Abstract

The object of this study was to test vascular endothelial growth factor (VEGF) for angiogenic activity in the rabbit corneal assay. VEGF doses ranging from 20 ng to 1000 ng were incorporated into a slow release polymer and implanted into the avascular rabbit cornea. Capillary formation in the cornea was visually analyzed on a daily basis and examined with histology, transmission electron microscopy and scanning electron microscopy of vascular corrosion casts on days 2 and 7 post-implantation. VEGF implants (200ng to 1000ng) consistently stimulated angiogenesis. This neovascularization occurred in the absence of inflammation. We conclude that VEGF acts directly on endothelial cells, initiating and mediating the formation of capillaries.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7539637

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  24 in total

Review 1.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  Physiological angiogenesis is a graded, not threshold, response.

Authors:  Stuart Egginton; Iman Badr; James Williams; David Hauton; Guus C Baan; Richard T Jaspers
Journal:  J Physiol       Date:  2010-11-08       Impact factor: 5.182

Review 3.  The roles of vascular endothelial growth factor in bone repair and regeneration.

Authors:  Kai Hu; Bjorn R Olsen
Journal:  Bone       Date:  2016-06-25       Impact factor: 4.398

4.  Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin).

Authors:  Roberta P A Manzano; Gholam A Peyman; Palwasha Khan; Petros E Carvounis; Muhamet Kivilcim; Min Ren; Jonathan C Lake; Patricia Chévez-Barrios
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

5.  Mesenchymal stem cells improve healing of the cornea after alkali injury.

Authors:  Diamantis Almaliotis; Georgios Koliakos; Eleni Papakonstantinou; Anastasia Komnenou; Angelos Thomas; Spiros Petrakis; Ilias Nakos; Eleni Gounari; Vasileios Karampatakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-23       Impact factor: 3.117

6.  CAPE suppresses VEGFR-2 activation, and tumor neovascularization and growth.

Authors:  Tae-Wook Chung; Seok-Jo Kim; Hee-Jung Choi; Choong-Hwan Kwak; Kwon-Ho Song; Seok-Jong Suh; Keuk-Jun Kim; Ki-Tae Ha; Young-Guk Park; Young-Chae Chang; Hyeun Wook Chang; Young-Choon Lee; Cheorl-Ho Kim
Journal:  J Mol Med (Berl)       Date:  2012-08-31       Impact factor: 4.599

7.  Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells.

Authors:  Noriyuki Ouchi; Hideki Kobayashi; Shinji Kihara; Masahiro Kumada; Kaori Sato; Tatsuya Inoue; Tohru Funahashi; Kenneth Walsh
Journal:  J Biol Chem       Date:  2003-10-13       Impact factor: 5.157

8.  The effect of bevacizumab on corneal neovascularization in rabbits.

Authors:  Wung-Jae Kim; Hee-Ok Jeong; Sung-Kun Chung
Journal:  Korean J Ophthalmol       Date:  2010-08-03

9.  Topically administered bevacizumab had longer standing anti-angiogenic effect than subconjunctivally injected bevacizumab in rat corneal neovacularization.

Authors:  Jae Kim; Dong Kim; Eun-Soon Kim; Myoung Joon Kim; Hungwon Tchah
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

10.  Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization.

Authors:  Olga Dratviman-Storobinsky; Bat-Chen R Avraham-Lubin; Murat Hasanreisoglu; Nitza Goldenberg-Cohen
Journal:  Mol Vis       Date:  2009-11-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.